JPIAMR at the AMR Multi-Stakeholder Partnership Platform Plenary Assembly

JPIAMR took part in the 2nd Annual Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform (MSPP) that was held on 16 November in Jeddah, Saudi Arabia. The MSPP was established and facilitated by the Quadripartite organizations (FAO, UNEP, WHO and WOAH) in 2023 with the aim to catalyse a global movement for action against antimicrobial resistance (AMR) by fostering cooperation between a diverse range of stakeholders at all levels across the One Health spectrum.

The platform’s members shared progress and experiences since its inception and worked together on formulating concrete steps for implementation of the UNGA political declaration on AMR from September this year.

The annual assembly was held in conjunction with the Fourth High-level Ministerial Conference on AMR, which highlighted efforts and ambitions in infection prevention, diagnostics, and research and innovation. The importance of inclusivity of voices and perspectives and of securing sustainable financial resources to support all aspects of AMR mitigation was highlighted by panelists and speakers.

A few key points from JPIAMR’s perspective:

  • Basic research and innovation, and good scientists, are needed for sustainable access to antibiotics.
  • Repeated calls for comprehensive funding for research and innovation with a One Health perspective, from public and private sector representatives.
  • Research and knowledge valorisation in infection prevention, diagnostics, and optimal use of existing antibiotics are accessible solutions for immediate action.
  • To tackle AMR, we need to also recognize how it is situated in a system of poor basic health care, lack of clean water and sanitation, impact from conflicts and climate change, and the vulnerable balance between access to/excess of medications.
Call picture AMR Interventions call 2024.

New projects in the area of AMR interventions

Thirteen projects involving 64 partners from 15 different countries have been recommended for funding within the JPIAMR 17th transnational call: Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments. The call was within the framework of the ERA‐NET JPIAMR-ACTION and the total funding amount is 17,2 M€.

The projects aim to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections, by focusing on the two topics of the call:

  • To design novel or improved interventions to prevent, mitigate and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance.
  • To improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

Read more about the projects.

JPIAMR team submitting the EUP OHAMR proposal.

Proposal for European partnership on OHAMR submitted!

Last week, we finally submitted the proposal for the Horizon Europe partnership on One Health AntiMicrobial Resistance (EUP OHAMR) to the European Commission (EC).

The EUP OHAMR will consist of 51 organisations from 28 countries that together with the EC will commit over 340 MEUR over 10 years to boost One Health AMR R&I in all its dimensions: coordinating joint transnational calls, actions to strengthen the capacity of the AMR research community, provide frameworks for alignment of policy and stakeholder engagement, and tools to valorise the new knowledge for the benefit of citizens and society as a whole.

Thank you to all partners for your cooporation and support to develop the proposal!

Livestok, petri dish with bacteria, people in city street.

Job vacancies, European partnership on One Health AMR

The European partnership on One Health AMR (OHAMR) is one of the key partnerships that has been identified by the European Commission within the framework of the Horizon Europe programme to support Resarch & Innovation to respond to the challenges of antimicrobial resistance (AMR). The first call and launch of other activities of this joint research programme between the European Commission and Member States are planned to take place in 2025.

The new partnership builds on the work of the Joint Programming Initiative on AMR (JPIAMR), but has a bigger ambition, as well as a stronger integration of social sciences and humanities, support of innovation, and international engagement to address the challenges of AMR.

The OHAMR partnership will be coordinated by the Swedish Research Council (SRC), who is currently hosting the JPIAMR secretariat. The SRC is now recruiting a Head of secretariat and a Scientific adviser to join the JPIAMR/OHAMR team in Stockholm, Sweden.

The application deadline for both positions is 20 August 2024.

Head of secretariat, European partnership on One Health AMR for the Swedish Research Council

Ref no: 2.2.1-2024-06278

As Head of the secretariat, you will coordinate and manage the European partnership OHAMR, with support from the secretariat. You will also lead and allocate other tasks within the secretariat, linked to the JPIAMR and other EU projects already in progress in the AMR area. The role requires some travel, primarily within the EU.

The tasks include:

  • Acting as project leader for the Swedish Research Council’s coordination of the European partnership OHAMR. This includes leading the coordination of the international collaboration according to the agreed governance structure of the partnership, and to ensure correct budget follow-up and reporting on the project to the EU.
  • Leading and delegating the work within the OHAMR secretariat, and coordinating the work within OHAMR as well as for the JPIAMR and EU projects within AMR that are already in progress.
  • participating in the Swedish Research Council’s work on establishing and further developing overarching internal procedures for coordination and participation in partnerships.

Your background

We put great emphasis on your personal qualities. To fit in and be happy in the role, we are looking for a person who is committed, proactive, and has well-developed strategic thinking and collaborative abilities. You have a well-developed ability to plan, organise, and communicate tasks in a structured way, at the same time as being flexible and able to adapt when conditions change. You show good judgement in balancing interests and decision-making. You are communicative and have the ability to establish trusting and good relationships in both external and internal contexts. You are good at picking up nuances and acting in a non-prestigious way.

In addition to these personal qualities, you also need to have:

  • an academic degree in medicine and health or another AMR-relevant subject area
  • documented experience of managing a team in major projects of relevance to the position
  • experience of driving projects forward in a structured way and documenting the work on an ongoing basis
  • knowledge of speaking and writing in Swedish
  • good speaking and writing abilities in English, and good ability in presenting results in a way adapted to the target group

It is an advantage if you have:

  • a doctoral degree in medicine and health, or alternatively corresponding meriting experience of relevance to AMR research
  • worked with AMR-related research strategy and/or policy
  • experience of international research collaboration
  • experience of Swedish public administration
  • experience of EU projects/EU administration
  • good speaking and writing abilities in Swedish

More information

See the full job description and information on how to apply on the Swedish Research Council’s website:

.

Scientific adviser to the Swedish Research Council’s international AMR work

Ref no: 2.2.1-2024-06279

As scientific adviser, you will be part of the OHAMR secretariat at the Swedish Research Council and act as deputy project manager of the upcoming European partnership OHAMR. Through operational work within the OHAMR secretariat, you will get a good overview of all the ongoing activities of the partnership, which forms the basis for driving forward and widening the programme in a strategic way, in consultation with the Head of secretariat. The role will periodically require extensive travel.

The tasks include:

  • through strategic scientific work, helping to develop the OHAMR partnership as a central actor within the global AMR research work
  • monitoring and reporting relevant initiatives within antimicrobial resistance, at national, European, and global level, and contributing to linking OHAMR’s internal and external communication in relevant events
  • acting as deputy project manager for the Swedish Research Council’s coordination of the European partnership OHAMR and working operationally with the secretariat’s various activities within OHAMR and other EU projects within AMR
  • participating in the Swedish Research Council’s other national and international work on AMR.

Your background

We put great emphasis on your personal qualities. To fit in and be happy in the role, you need to have very good collaborative abilities and be able to establish trusting and good relationships in both external and internal contexts. You are good at picking up nuances and acting in a non-prestigious way. You have a well-developed ability to plan, organise, and communicate tasks in a structured way, at the same time as being flexible and able to adapt when conditions change. You are a good communicator and show good judgement in balancing interests and decision-making.

In addition to these personal qualities, you also need to have:

  • a doctoral degree in medicine and health, or alternatively corresponding meriting experience of relevance to AMR research
  • experience of international research collaboration
  • experience of representing an organisation in international collaborations
  • good speaking and writing abilities in English, and good ability in presenting results in a way adapted to the target group
  • knowledge of speaking and writing in Swedish

It is an advantage if you have:

  • worked with AMR-related research matters
  • experience of Swedish public administration
  • experience of EU projects/EU administration
  • good speaking and writing abilities in Swedish

More information

See the full job description and information on how to apply on the Swedish Research Council’s website:

Cover and a couple of pages from the draft OHAMR SRIA.

Online Consultation: The Strategic Research and Innovation Agenda of the European partnership OHAMR

The European partnership on One Health AMR (OHAMR) is one of the key European partnerships that has been identified by the European commission within the framework of the Horizon Europe programme to support research and innovation to respond to the challenges of AMR. The OHAMR Strategic Research and Innovation Agenda (SRIA) presents the vision, missions, objectives, scientific focus, and implementation plan of the OHAMR, and serves as the strategic foundation of the partnership to guide its future actions:

The OHAMR SRIA is almost finalised, and we now invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide their final feedback by answering a short survey:

A word template of the survey is also available to facilitate the consultation process. However, only the answers collected through the on-line survey tool will be analysed.

The consultation is open until May 30th, 17h CEST.

For questions regarding the consultation, please contact ohamr@vr.se.

For more information about the OHAMR Partnership, visit www.ohamr.eu.

Call picture for JPIAMR Diagnostics and Surveillance call 2023

Research call on AMR Diagnostics and surveillance now open

The call Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance is now open. 

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 22 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

Partners working in eligible Least Developed Countries (LDCs) in in sub-Saharan Africa can be funded by the Swedish International Development Cooperation Agency (Sida).

The call will follow a two-step evaluation procedure and the deadline for pre-proposals is 7 March 2022. The full call text and the link to the online submission platform can be found on the call page: 

Call page “AMR diagnostics and surveillance 2023”

Webinar for applicants

A live webinar for applicants will be organised on the 24th of January 2023. This webinar will present the call and the partner search tool. Representatives from funders participating in the call will answer questions live.

Registration page Webinar for applicants

Online Consultation: Research and Innovation Objectives for the OH AMR Partnership

The One Health Antimicrobial Resistance partnership (OH AMR) has been identified by the European Commission as one of the European Partnerships of Horizon Europe. Currently, the Research and Innovation Objectives of OH AMR are under preparation, and we now invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide feedback on the elements included in the Research and Innovations Objectives.

Please activate the online survey for this purpose here: Survey: OH AMR Research and Innovation Objectives

The consultation is open until 16 January 2023.

The online consultation outcome will guide the development of the final Research and Innovations Objectives, which will be included in the OH AMR Strategic Research and Innovation Agenda.

The Research and Innovation Objectives have been developed through a number of consultations during 2022. The latest version of the document can be found here: Research and Innovation Objectives of the OH AMR Partnership (pdf, 1 MB)

For questions regarding the consultation, please contact secretariat.jpiamr@vr.se

About the OH AMR Partnership

In the research framework of Horizon Europe and collaboration with the member states, the European Commission has identified 49 new European Partnerships, one of which is the “One Health Antimicrobial Resistance Partnership.” 

The future One Health AMR (OH AMR) Partnership will be a joint research program co-funded by the European Commission and EU member states. The OH AMR Partnership aims to coordinate and align AMR activities and funding between countries and the European level. With a mix of EU and national public R&I funding, the OH AMR partnership will develop joint calls and activities to address the objectives of the European One Health Action Plan against AMR and the WHO Global Action Plan on AMR to reduce the burden of AMR.

For more information about the OH AMR Partnership, visit www.ohamr.eu

Shadows of people on a colourful background.

Six new networks in the area of diagnostics and surveillance

Six networks have been recommended for funding within the JPIAMR 15th transnational call: Diagnostics and Surveillance Networks. The networks include 228 partners from 40 countries and the total funding amount is 300 000 € plus up to 100 000 € fort start-up and final joint workshops.

The networks assemble leading experts and stakeholders with an intent to facilitate the development, optimisation and use of diagnostic and surveillance tools, technologies and systems.

For the first time, a network focussed on antifungal resistance has been included.

Learn more about the networks

Northern lights

New projects in the area of therapeutics

Thirteen projects involving 72 partners from 15 different countries have been recommended for funding within the JPIAMR 14th transnational call: Disrupting drug Resistance Using Innovative Design. The call was within the framework of the ERA‐NET JPIAMRACTION and the total funding amount is 15,4 M€.

The projects aim to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

Learn more about the projects

Call picture for JPIAMR Diagnostics and Surveillance call 2023

Pre-announcement: Research call on AMR diagnostics and surveillance

We are pleased to pre‐announce the transnational call Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance.

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 21 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

N.B New opening date! The call opens on 16 January 2023.

Read more on the call page